Intra-coronary physiology in contemporary percutaneous coronary intervention and anginal therapy with a focus on

Zaheer Alisiddiq1, Harish Sharma1,2, James Cotton3,4

  • 1Department of Cardiology, New Cross Hospital, The Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom.

PubMed

Insights

Pressure wire measurements are revolutionizing coronary artery disease (CAD) treatment. Microvascular assessments help identify angina causes, enabling personalized therapy for better patient outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Coronary physiological measurements, particularly pressure wire-guided revascularization, are increasingly evidence-supported in treating coronary artery disease (CAD).
  • Advances in microvascular assessment allow for the diagnosis of angina etiology in patients without obstructive epicardial coronary artery disease.

Purpose of the Study:

  • To examine the role and impact of pressure wire indices in clinical outcomes.
  • To discuss future directions in the application of pressure wire technology for CAD management.

Main Methods:

  • Review of current literature on pressure wire indices and their application.
  • Analysis of evidence supporting pressure wire-guided revascularization.
  • Discussion of techniques for microvascular assessment.

Main Results:

  • Pressure wire measurements significantly influence treatment decisions in CAD.
  • Microvascular assessment aids in diagnosing non-obstructive coronary artery disease related angina.
  • Tailored therapeutic strategies based on physiological measurements improve patient management.

Conclusions:

  • Pressure wire technology is transforming CAD treatment paradigms.
  • Accurate physiological assessment is crucial for effective angina management.
  • Future research should focus on refining pressure wire indices and expanding their clinical utility.

Related Concept Videos

Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
596
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
526
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K